Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Michelle Van Name MD

Michelle A. Van Name MD

Associate Professor of Pediatric Endocrinology, Yale School of Medicine, New Haven, Connecticut

Dr. Van Name is an Associate Professor of Pediatrics in the Division of Endocrinology at the Yale School of Medicine. Her research focuses on improving diabetes management in those with glycemia above target, including through the use of diabetes technology, adjunctive agents, and treating the chronic disease of obesity. She aims to study strategies that improve outcomes in young people at highest risk of acute and chronic complications of diabetes, enhance quality of life, and reduce disparities in diabetes outcomes.

Disclosures

Dr. Van Name reports the following:

  • Research: Provention Bio, Novo Nordisk, Mannkind
  • Consultant: Novo Nordisk

 

Recent Contributions to PracticeUpdate:

  1. GLP-1 Receptor Agonists in Adolescents With Overweight or Obesity With or Without Type 2 Diabetes Multimorbidity
  2. GLP-1 Analogues as Adjunctive Therapy for Patients With Type 1 Diabetes
  3. Quality of Diabetes Health Care During Transition From Paediatric to Adult Care
  4. Type 1 Diabetes Management and Outcomes

Most Read This Week

Recently Updated